TERUMO CORP/ADR (TRUMY) Raised to “Buy” at ValuEngine

ValuEngine upgraded shares of TERUMO CORP/ADR (OTCMKTS:TRUMY) from a hold rating to a buy rating in a research note released on Friday.

TRUMY opened at $59.00 on Friday. The company has a debt-to-equity ratio of 0.46, a quick ratio of 1.77 and a current ratio of 2.51. TERUMO CORP/ADR has a 1 year low of $50.64 and a 1 year high of $62.05. The company has a market cap of $22.41 billion, a P/E ratio of 26.94, a P/E/G ratio of 4.09 and a beta of 0.31.

About TERUMO CORP/ADR

Terumo Corporation develops, manufactures, and distributes medical devices and services worldwide. It provides products for use in cardiothoracic surgery, interventional procedure, and medicine transfusion. The company offers vascular intervention devices, such as introducer sheathes, guide wires, angiographic catheters, and radial artery compression devices; therapeutic devices; and intravascular imaging systems, including optical frequency domain imaging and intravascular ultrasound systems.

Read More: Relative Strength Index

To view ValuEngine’s full report, visit ValuEngine’s official website.

Receive News & Ratings for TERUMO CORP/ADR Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TERUMO CORP/ADR and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply